ANF vs. OLMA
Compare and contrast key facts about Abercrombie & Fitch Co. (ANF) and Olema Pharmaceuticals, Inc. (OLMA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ANF or OLMA.
Key characteristics
| ANF | OLMA | |
|---|---|---|
| YTD Return | 37.75% | -27.51% |
| 1Y Return | 421.55% | 87.29% |
| 3Y Return (Ann) | 48.15% | -28.76% |
| Sharpe Ratio | 7.34 | 1.28 |
| Daily Std Dev | 56.71% | 87.78% |
| Max Drawdown | -86.59% | -96.26% |
| Current Drawdown | -13.17% | -81.34% |
Fundamentals
| ANF | OLMA | |
|---|---|---|
| Market Cap | $6.23B | $556.35M |
| EPS | $6.23 | -$2.14 |
| Revenue (TTM) | $4.28B | $0.00 |
| Gross Profit (TTM) | $2.10B | $0.00 |
| EBITDA (TTM) | $632.13M | -$104.58M |
Correlation
The correlation between ANF and OLMA is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ANF vs. OLMA - Performance Comparison
In the year-to-date period, ANF achieves a 37.75% return, which is significantly higher than OLMA's -27.51% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ANF vs. OLMA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Abercrombie & Fitch Co. (ANF) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ANF vs. OLMA - Dividend Comparison
Neither ANF nor OLMA has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANF Abercrombie & Fitch Co. | 0.00% | 0.00% | 0.00% | 0.00% | 0.98% | 4.63% | 3.99% | 4.59% | 6.67% | 2.96% | 2.79% | 2.43% |
OLMA Olema Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
ANF vs. OLMA - Drawdown Comparison
The maximum ANF drawdown since its inception was -86.59%, smaller than the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for ANF and OLMA. For additional features, visit the drawdowns tool.
Volatility
ANF vs. OLMA - Volatility Comparison
The current volatility for Abercrombie & Fitch Co. (ANF) is 14.25%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 16.02%. This indicates that ANF experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ANF vs. OLMA - Financials Comparison
This section allows you to compare key financial metrics between Abercrombie & Fitch Co. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities